Lorlatinib and Artemether: Interaction Details
- Lorlatinib
- Lorbrena
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Lorlatinib and Artemether interaction:
Artemether
We don't have a separate drug information page for Artemether. The FDA's drug directory lists it as part of Coartem (artemether and lumefantrine). Read the Artemether and Lumefantrine drug information page → Have a question about Artemether? Ask a pharmacist, free →
What Happens When You Take Lorlatinib With Artemether
What can happen when they are taken together (rated Major)
Reduced artemether/lumefantrine exposure, reduced of artemether/lumefantrine, loss of antimalarial efficacy, reduced exposure and reduced efficacy of CYP3A4 substrates
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Caution is warranted when artemether/lumefantrine is given together with CYP3A4 substrates that also act as CYP3A4 . Such may lower exposure to artemether/lumefantrine, to the CYP3A4 substrates, or to both, which could diminish the efficacy of either agent and result in loss of antimalarial efficacy.1
The Lorlatinib and Artemether Interaction, Explained
Lorlatinib (Lorbrena) may lower the amount of artemether in your body. Lorlatinib is a cancer medicine that can speed up a liver enzyme () that breaks down artemether, an antimalarial usually given with lumefantrine. If artemether is cleared faster, it may work less well against malaria. Artemether and lumefantrine can also affect heart rhythm (the ), which your team may keep in mind. This is a theoretical concern based on how the drugs work, not on proven cases, but it is rated as important because malaria can be serious.
Keep taking your medicines as prescribed and tell your pharmacist or doctor about both. Your care team can decide how best to manage this and may monitor you more closely.
Mechanism: Lorlatinib is a (it also induces other pathways) and may reduce exposure to artemether and lumefantrine, which are CYP3A4 . The data also note possible in the other direction and . Artemether is converted to the active dihydroartemisinin, but the key concern here is reduced overall antimalarial exposure.
- Direction: decreased artemether/lumefantrine and , with possible loss of antimalarial .
- Evidence: theoretical, no specific clinical data. Onset unspecified. Severity on file: major.
- Management: exert caution with . Individualize therapy, monitor for treatment failure (parasitological and clinical response), and consider and electrolyte monitoring given additive QT risk.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Lorlatinib and Artemether Interact
The likely mechanism
of -mediated of artemether/lumefantrine; induction of CYP3A4-mediated metabolism by artemether/lumefantrine;
How to Manage the Lorlatinib and Artemether Interaction
Your care team can manage this by individualizing your treatment and monitoring you.
- Keep taking both medicines exactly as prescribed. Do not stop or change either one on your own.
- Tell your pharmacist and prescriber about all your medicines, especially if you are being treated for malaria.
- Your team may monitor you more closely to make sure the malaria treatment is working, and may adjust or individualize your plan.
- Report any fever that returns or does not improve, and any fainting, dizziness, or palpitations.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Lorlatinib or Artemether need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Lorlatinib and Artemether: Common Questions
How serious is the Lorlatinib and Artemether interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Lorlatinib and Artemether interaction managed?
Your care team can manage this by individualizing your treatment and monitoring you. Keep taking both medicines exactly as prescribed. Do not stop or change either one on your own. Tell your pharmacist and prescriber about all your medicines, especially if you are being treated for malaria. Your team may monitor you more closely to make sure the malaria treatment is working, and may adjust or indi… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Lorlatinib and Artemether Interaction
Ask in your own words about taking Lorlatinib and Artemether together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: COARTEM® oral tablets, artemether lumefantrine oral tablets. Novartis Pharmaceuticals Corporation (per DailyMed), East Hanover, NJ, 2025. DailyMed
Other Serious Interactions of Lorlatinib and Artemether
Also serious with Artemether
- Ketoconazole TopicalContraindicated
- CarbamazepineContraindicated
- DronedaroneContraindicated
- FluconazoleContraindicated
Also serious with Lorlatinib
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Artemether
- GrapefruitMajor
- Activated CharcoalMajor
- American HelleboreMajor
- ArsenicMajor
- CesiumMajor
- EphedraMajor
- Sida CordifoliaMajor
- Slippery ElmModerate
- + 22 more
With Lorlatinib
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- Black PepperModerate
- GrapeModerate
- + 150 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.